Nanjing King-friend Biochemical Pharmaceutical Co Ltd
SSE:603707
Intrinsic Value
The intrinsic value of one Nanjing King-friend Biochemical Pharmaceutical Co Ltd stock under the Base Case scenario is 19.18 CNY. Compared to the current market price of 11.24 CNY, Nanjing King-friend Biochemical Pharmaceutical Co Ltd is Undervalued by 41%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation History
Nanjing King-friend Biochemical Pharmaceutical Co Ltd
Fundamental Analysis


Revenue & Expenses Breakdown
Nanjing King-friend Biochemical Pharmaceutical Co Ltd
Balance Sheet Decomposition
Nanjing King-friend Biochemical Pharmaceutical Co Ltd
Current Assets | 6.9B |
Cash & Short-Term Investments | 2B |
Receivables | 1.2B |
Other Current Assets | 3.8B |
Non-Current Assets | 2.5B |
Long-Term Investments | 81.9m |
PP&E | 1.2B |
Intangibles | 750.3m |
Other Non-Current Assets | 473.5m |
Free Cash Flow Analysis
Nanjing King-friend Biochemical Pharmaceutical Co Ltd
CNY | |
Free Cash Flow | CNY |
Earnings Waterfall
Nanjing King-friend Biochemical Pharmaceutical Co Ltd
Revenue
|
3.9B
CNY
|
Cost of Revenue
|
-2.3B
CNY
|
Gross Profit
|
1.6B
CNY
|
Operating Expenses
|
-2B
CNY
|
Operating Income
|
-392m
CNY
|
Other Expenses
|
-30.9m
CNY
|
Net Income
|
-423m
CNY
|
Profitability Score
Profitability Due Diligence
Nanjing King-friend Biochemical Pharmaceutical Co Ltd's profitability score is 51/100. The higher the profitability score, the more profitable the company is.
Score
Nanjing King-friend Biochemical Pharmaceutical Co Ltd's profitability score is 51/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Nanjing King-friend Biochemical Pharmaceutical Co Ltd's solvency score is 74/100. The higher the solvency score, the more solvent the company is.
Score
Nanjing King-friend Biochemical Pharmaceutical Co Ltd's solvency score is 74/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Nanjing King-friend Biochemical Pharmaceutical Co Ltd
According to Wall Street analysts, the average 1-year price target for Nanjing King-friend Biochemical Pharmaceutical Co Ltd is 19.04 CNY with a low forecast of 17.17 CNY and a high forecast of 21.36 CNY.
Dividends
Current shareholder yield for Nanjing King-friend Biochemical Pharmaceutical Co Ltd is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one Nanjing King-friend Biochemical Pharmaceutical Co Ltd stock under the Base Case scenario is 19.18 CNY.
Compared to the current market price of 11.24 CNY, Nanjing King-friend Biochemical Pharmaceutical Co Ltd is Undervalued by 41%.